Novo Nordisk Sues Hims For Patent Infringement Over Compounded Semaglutide Sales
WILMINGTON, Del. — The manufacturer of Ozempic, Wegovy and Rybelsus on Feb. 9 sued an online health care provider in Delaware federal court for patent infringement stemming from its marketing and...To view the full article, register now.
Already a subscriber? Click here to view full article